Health news Video. Second Alzheimer's slowing drug to seek approval in the US Copy/paste the link below: Copy Copy/paste the article video embed link below: Copy Updated: 17/07/2023 - 18:47 GMT+2 Donanemab has proven to slow disease progression by several months in some patients but has also shown serious side effects. Read full article Top stories Now playing Next Second Alzheimer's slowing drug to seek approval in the US Now playing Next Mourners lay flowers after deadly bus fire in western Switzerland Now playing Next Latest news bulletin | March 11th, 2026 – Evening Now playing Next Vasectomy, yes: Access to permanent contraception unequal in Poland Now playing Next Could this new material make rugby safer for young players? Now playing Next David Beckham participates in Healthy Cities school programme in Doha Now playing Next Iran unleashes intense strikes across Gulf as Hormuz crisis deepens Now playing Next Qatar warns the world Iran war could yield 'catastrophic results' Now playing Next Swiss bus fire killing six 'intentional,' police say Now playing Next British Airways cancels Abu Dhabi service ‘until later this year’ Now playing Next Iran war enters day 12 as European leaders voice frustration Now playing Next France's Macron opposed to lifting sanctions against Russia Now playing Next EU reinforces cooperation with Azerbaijan on security and energy Now playing Next Iran war: Is the EU a mere spectator or diplomatic player? MEPs debate on The Ring Now playing Next Sir Don McCullin: 'My life, thanks to photography, has had purpose and meaning' Now playing Next Hungary sends fact-finding mission over Druzhba pipeline as Kyiv refuses to recognise delegation More videos
Now playing Next Hungary sends fact-finding mission over Druzhba pipeline as Kyiv refuses to recognise delegation
Europe Today Cutting off Iranian lifeline for Hezbollah is critical, Lebanese minister tells Euronews